BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1490701)

  • 1. Increased platelet activity in diabetic macroangiopathy.
    Diamantopoulos EJ; Raptis SA; Moulopoulos SD
    Horm Metab Res Suppl; 1992; 26():95-102. PubMed ID: 1490701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
    Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of the level of plasma beta-thromboglobulin in diabetes].
    Stoltz JF; Voisin P; Drouin P; Pointel JP; Benisti G
    Biomedicine; 1980; 33(6):194-6. PubMed ID: 6163487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell deformability index in diabetic retinopathy.
    Diamantopoulos EJ; Raptis SA; Moulopoulos SD
    Horm Metab Res; 1987 Nov; 19(11):569-73. PubMed ID: 3428873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal typical pattern of platelet function and thromboxane generation in unstable angina.
    Zahavi M; Zahavi J; Schafer R; Firsteter E; Laniado S
    Thromb Haemost; 1989 Nov; 62(3):840-5. PubMed ID: 2531938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostasis in diabetics.
    Misz M; Beck P; Udvardy M; Rák K
    Acta Med Hung; 1984; 41(2-3):93-102. PubMed ID: 6235479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease.
    Galt SW; McDaniel MD; Ault KA; Mitchell J; Cronenwett JL
    J Vasc Surg; 1991 Dec; 14(6):747-55; discussion 755-6. PubMed ID: 1720468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segmental blood flow and rheological determinants in diabetic patients with peripheral occlusive arterial disease.
    Vigilance JE; Reid HL
    J Diabetes Complications; 2008; 22(3):210-6. PubMed ID: 18413225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J; Zahavi M
    Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study.
    Breddin HK; Krzywanek HJ; Althoff P; Kirchmaier CM; Rosak C; Schepping M; Weichert W; Ziemen M; Schöffling K; Uberla K
    Int Angiol; 1986; 5(3):181-95. PubMed ID: 3104511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo platelet release in myeloproliferative disorders.
    Ireland H; Lane DA; Wolff S; Foadi M
    Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
    Artery; 1980; 8(1):73-9. PubMed ID: 6158934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of soluble E-selectin in diabetic patients with severe symptomatic peripheral arterial occlusive disease requiring angioplasty. A possible role in diabetic vascular disease?
    Elhadd TA; Kennedy G; McLaren M; Stonebridge PA; Shaw WJ; Belch JJ
    Int Angiol; 2000 Jun; 19(2):171-5. PubMed ID: 10905802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease.
    Boulbou MS; Koukoulis GN; Vasiou KG; Petinaki EA; Gourgoulianis KI; Fezoulidis IB
    Int Angiol; 2004 Mar; 23(1):18-24. PubMed ID: 15156125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E
    Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography.
    Janka HU; Standl E; Mehnert H
    Horm Metab Res Suppl; 1981; 11():26-9. PubMed ID: 6172351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcutaneous oximetry in symptomatic diabetics].
    Cavallini M; Lombardi A; Franciotti G; Congedo L; Fraticelli E; Testa M; Fallucca F
    Minerva Med; 1992 Sep; 83(9):491-6. PubMed ID: 1436597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased platelet aggregation in diabetic patients with microangiopathy despite good glycemic control.
    Kajita K; Ishizuka T; Miura A; Kanoh Y; Ishizawa M; Kimura M; Yasuda K
    Platelets; 2001 Sep; 12(6):343-51. PubMed ID: 11672473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired plasma viscosity via increased cholesterol levels in peripheral occlusive arterial disease [correction of disase].
    Ercan M; Koksal C; Konukoglu D; Bozkurt AK; Onen S
    Clin Hemorheol Microcirc; 2003; 29(1):3-9. PubMed ID: 14561898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls.
    Hendra TJ; Oughton J; Jeremy JY; Smith CC; Betteridge DJ; Dandona P; Yudkin JS
    Diabetes Res; 1988 Jul; 8(3):117-22. PubMed ID: 2976336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.